{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/20/3348448/0/en/creative-medical-technology-holdings-successfully-completes-enrollment-and-treatment-across-entire-fda-cleared-adapt-trial-including-opioid-cohort-advancing-celz-201-olastrocel-tow.html", "message": "News view counter 894454 successfully enlarged"}